Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free IEX Stock Alerts

IDEX (IEX) Financials

IDEX logo
$238.72 -0.41 (-0.17%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$238.88 +0.15 (+0.06%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for IDEX

Annual Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 283 271 337 411 426 378 449 587 596 505 483
Consolidated Net Income / (Loss)		 283 271 337 411 426 378 449 587 596 505 483
Net Income / (Loss) Continuing Operations		 283 271 337 411 426 378 449 587 596 505 483
Total Pre-Tax Income 		392 369 455 529 533 470 580 749 760 639 633
Total Operating Income		 419 435 493 569 579 521 637 751 733 677 699
Total Gross Profit		 904 931 1,027 1,118 1,125 1,027 1,225 1,427 1,447 1,445 1,539
Total Revenue		 2,021 2,113 2,287 2,484 2,495 2,352 2,765 3,182 3,274 3,269 3,458
Operating Revenue		 2,021 2,113 2,287 2,484 2,495 2,352 2,765 3,182 3,274 3,269 3,458
Total Cost of Revenue		 1,116 1,182 1,261 1,366 1,370 1,324 1,540 1,755 1,827 1,824 1,919
Operating Cost of Revenue		 1,116 1,182 1,261 1,366 1,370 1,324 1,540 1,755 1,827 1,824 1,919
Total Operating Expenses		 485 496 533 549 546 507 588 676 714 768 840
Selling, General & Admin Expense		 474 492 525 537 525 495 578 653 704 759 819
Restructuring Charge		 11 3.67 8.46 12 21 12 9.30 23 11 9.30 21
Total Other Income / (Expense), net		 -27 -66 -38 -40 -46 -50 -57 -2.00 28 -38 -67
Interest & Investment Income		 - - - - - - - -41 -52 -45 -64
Other Income / (Expense), net		 15 -21 6.88 3.99 -1.80 -5.60 -16 39 80 6.60 -2.30
Income Tax Expense		 110 97 118 118 107 93 131 163 165 135 150
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - 0.00 0.00 -0.10 -0.20 -0.50 -0.40 -0.70
Basic Earnings per Share		 $3.65 $3.57 $4.41 $5.36 $5.62 $4.98 $5.91 $7.74 $7.87 $6.66 $6.41
Weighted Average Basic Shares Outstanding		 77.13M 75.80M 76.23M 76.41M 75.60M 75.70M 76M 75.70M 75.60M 75.70M 75.30M
Diluted Earnings per Share		 $3.62 $3.53 $4.36 $5.29 $5.56 $4.94 $5.88 $7.71 $7.85 $6.64 $6.41
Weighted Average Diluted Shares Outstanding		 77.97M 76.76M 77.33M 77.56M 76.50M 76.40M 76.40M 76M 75.90M 75.90M 75.30M
Weighted Average Basic & Diluted Shares Outstanding		 77.50M 75.90M 76.50M 76.60M 76.21M 75.89M 76.12M 75.52M 75.64M 75.78M 74.35M
Cash Dividends to Common per Share		 $1.28 $1.36 $1.48 $1.72 $2.00 $2.00 $2.16 $2.40 $2.56 $2.76 $2.84

Quarterly Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 109 121 141 119 123 96 132 128 128 120 143
Consolidated Net Income / (Loss)		 108 121 141 119 123 95 131 128 128 120 143
Net Income / (Loss) Continuing Operations		 108 121 141 119 123 95 131 128 128 120 143
Total Pre-Tax Income 		140 155 179 154 151 125 170 171 168 157 186
Total Operating Income		 161 161 183 168 165 142 188 186 184 172 200
Total Gross Profit		 337 357 367 354 367 369 392 391 387 398 427
Total Revenue		 789 801 807 798 863 814 865 879 899 887 921
Operating Revenue		 789 801 807 798 863 814 865 879 899 887 921
Total Cost of Revenue		 452 443 440 444 496 445 473 488 512 489 494
Operating Cost of Revenue		 452 443 440 444 496 445 473 488 512 489 494
Total Operating Expenses		 176 196 184 186 202 227 204 205 204 226 227
Selling, General & Admin Expense		 174 195 183 183 198 209 204 205 201 218 224
Restructuring Charge		 2.70 1.10 1.30 3.00 3.90 18 0.70 0.10 2.40 7.40 2.80
Total Other Income / (Expense), net		 -20 -6.70 -3.50 -14 -14 -18 -18 -15 -16 -15 -14
Interest & Investment Income		 - -9.40 -8.10 -10 - -16 -16 -17 -16 -16 -15
Other Income / (Expense), net		 -8.70 2.70 4.60 -3.30 2.60 -1.40 -2.40 1.20 0.30 0.60 1.30
Income Tax Expense		 32 33 38 36 28 29 39 43 39 37 43
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.30 -0.10 -0.10 -0.20 - -0.10 -0.50 -0.10 - -0.10 0.00
Basic Earnings per Share		 $1.43 $1.60 $1.86 $1.57 $1.63 $1.26 $1.74 $1.70 $1.71 $1.61 $1.94
Weighted Average Basic Shares Outstanding		 75.60M 75.70M 75.70M 75.70M 75.70M 75.70M 75.50M 75.10M 75.30M 74.30M 74M
Diluted Earnings per Share		 $1.44 $1.60 $1.86 $1.57 $1.61 $1.26 $1.74 $1.70 $1.71 $1.61 $1.93
Weighted Average Diluted Shares Outstanding		 75.90M 75.90M 75.90M 75.90M 75.90M 75.80M 75.50M 75.20M 75.30M 74.40M 74.20M
Weighted Average Basic & Diluted Shares Outstanding		 75.64M 75.70M 75.70M 75.72M 75.78M 75.54M 75.29M 74.85M 74.35M 74.02M 73.72M

Annual Cash Flow Statements for IDEX

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -181 -92 140 90 166 393 -171 -425 104 105 -53
Net Cash From Operating Activities		 360 400 433 479 528 569 565 557 717 668 680
Net Cash From Continuing Operating Activities		 360 400 433 479 528 569 565 557 717 668 680
Net Income / (Loss) Continuing Operations		 283 271 337 411 426 378 449 587 596 505 483
Consolidated Net Income / (Loss)		 283 271 337 411 426 378 449 587 596 505 483
Depreciation Expense		 36 38 38 39 40 42 47 51 57 69 76
Amortization Expense		 44 50 47 40 39 44 56 69 95 107 131
Non-Cash Adjustments To Reconcile Net Income		 4.42 53 22 32 39 24 33 4.20 -54 22 28
Changes in Operating Assets and Liabilities, net		 -6.64 -13 -12 -42 -14 82 -20 -153 23 -34 -37
Net Cash From Investing Activities		 -210 -509 -55 -81 -137 -173 -698 -917 -284 -1,007 -138
Net Cash From Continuing Investing Activities		 -210 -509 -55 -81 -137 -173 -698 -917 -284 -1,007 -138
Purchase of Property, Plant & Equipment		 -44 -38 -44 -56 -51 -52 -73 -68 -90 -65 -64
Acquisitions		 -195 -510 -38 -24 -87 -123 -577 -946 -312 -985 -76
Purchase of Investments		 - - - - - 0.00 -45 0.00 -29 0.00 0.00
Divestitures		 28 39 22 0.00 - 0.00 0.00 49 119 45 0.00
Sale and/or Maturity of Investments		 - - - - - 0.00 0.00 40 25 4.50 0.00
Other Investing Activities, net		 0.62 -0.02 5.48 -1.50 1.10 2.10 -2.80 7.30 3.50 -6.50 2.20
Net Cash From Financing Activities		 -296 47 -277 -290 -228 -43 -9.50 -38 -345 466 -633
Net Cash From Continuing Financing Activities		 -296 47 -277 -290 -228 -43 -9.50 -38 -345 466 -633
Repayment of Debt		 -424 -520 -201 -11 -52 -455 -355 -137 -251 -122 -424
Repurchase of Common Equity		 -211 -57 -29 -174 -55 -110 0.00 -148 -24 0.00 -248
Payment of Dividends		 -96 -103 -111 -127 -147 -152 -161 -177 -191 -205 -213
Issuance of Debt		 414 702 33 0.00 - 649 499 410 100 776 252
Other Financing Activities, net		 21 25 30 23 26 26 -6.70 - 22 17 -0.50
Effect of Exchange Rate Changes		 -35 -29 39 -17 - - - -28 16 -23 37
Cash Interest Paid		 34 37 37 36 37 35 36 37 51 47 72
Cash Income Taxes Paid		 113 109 105 91 109 87 118 176 200 171 135

Quarterly Cash Flow Statements for IDEX

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -28 82 84 -49 -12 -27 -42 30 -14 5.90 36
Net Cash From Operating Activities		 201 157 134 205 173 106 162 204 210 104 200
Net Cash From Continuing Operating Activities		 201 157 134 205 173 106 162 204 210 104 200
Net Income / (Loss) Continuing Operations		 108 121 141 119 123 95 131 128 128 120 143
Consolidated Net Income / (Loss)		 108 121 141 119 123 95 131 128 128 120 143
Depreciation Expense		 15 16 16 17 19 18 19 19 19 20 20
Amortization Expense		 24 25 24 27 32 32 32 33 34 34 33
Non-Cash Adjustments To Reconcile Net Income		 13 13 -0.20 4.60 5.00 14 5.80 5.00 3.60 21 6.10
Changes in Operating Assets and Liabilities, net		 40 -18 -48 38 -6.30 -53 -26 19 24 -91 -2.90
Net Cash From Investing Activities		 -194 -20 32 -1,004 -15 -10 -15 -96 -18 -20 -22
Net Cash From Continuing Investing Activities		 -194 -20 32 -1,004 -15 -10 -15 -96 -18 -20 -22
Purchase of Property, Plant & Equipment		 -22 -20 -16 -14 -16 -14 -15 -15 -20 -18 -23
Other Investing Activities, net		 0.60 0.00 0.50 -7.80 0.80 0.10 0.30 - 1.80 -2.70 0.70
Net Cash From Financing Activities		 -58 -41 -77 725 -141 -133 -216 -76 -208 -69 -139
Net Cash From Continuing Financing Activities		 -58 -41 -77 725 -141 -133 -216 -76 -208 -69 -139
Repayment of Debt		 -0.30 -0.20 -25 -1.40 -95 -30 -163 -93 -137 -46 -118
Repurchase of Common Equity		 -23 0.00 - - - -50 -50 -75 -73 -76 -77
Payment of Dividends		 -48 -49 -52 -52 -52 -52 -54 -54 -53 -53 -54
Issuance of Debt		 - - - 776 - 0.00 - 147 55 100 105
Other Financing Activities, net		 - 7.70 - - - -0.50 0.30 -1.00 0.70 5.80 4.80
Effect of Exchange Rate Changes		 22 -14 -3.70 24 - - 27 -2.60 2.00 -8.60 -2.10
Cash Interest Paid		 20 2.40 21 2.50 22 16 21 15 20 15 19
Cash Income Taxes Paid		 52 18 66 36 51 20 64 20 31 20 62

Annual Balance Sheets for IDEX

This table presents IDEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,805 3,155 3,400 3,474 3,814 4,414 4,917 5,512 5,865 6,745 6,927
Total Current Assets		 863 823 1,004 1,093 1,261 1,657 1,678 1,399 1,446 1,593 1,643
Cash & Equivalents		 328 236 376 466 633 1,026 855 430 534 621 580
Accounts Receivable		 260 273 294 312 298 293 356 443 428 466 522
Inventories, net		 239 253 260 280 293 290 370 471 421 430 479
Other Current Assets		 36 61 74 34 37 48 96 55 63 76 62
Plant, Property, & Equipment, net		 241 248 258 281 280 298 327 382 430 460 468
Total Noncurrent Assets		 1,702 2,084 2,137 2,100 2,272 2,459 2,912 3,731 3,989 4,692 4,816
Goodwill		 1,397 1,633 1,704 1,698 1,780 1,896 2,168 2,638 2,838 3,252 3,415
Intangible Assets		 288 436 415 383 388 416 597 948 1,012 1,285 1,247
Other Noncurrent Operating Assets		 17 16 18 19 104 148 147 145 139 156 154
Total Liabilities & Shareholders' Equity		 2,805 3,155 3,400 3,474 3,814 4,414 4,917 5,512 5,865 6,745 6,927
Total Liabilities		 1,362 1,611 1,513 1,479 1,551 1,874 2,114 2,472 2,324 2,951 2,901
Total Current Liabilities		 310 309 361 365 358 399 480 544 500 630 575
Short-Term Debt		 - - - 0.48 0.39 0.10 - 0.00 0.60 101 0.70
Accounts Payable		 129 129 147 143 138 152 179 209 180 198 225
Accrued Expenses		 154 153 185 188 180 209 260 289 272 279 297
Dividends Payable		 26 26 29 33 39 38 41 46 49 53 53
Total Noncurrent Liabilities		 1,053 1,302 1,152 1,115 1,193 1,475 1,634 1,929 1,824 2,322 2,325
Long-Term Debt		 840 1,014 859 848 849 1,044 1,190 1,469 1,325 1,860 1,820
Noncurrent Deferred & Payable Income Tax Liabilities		 110 166 138 128 147 164 196 264 292 267 303
Other Noncurrent Operating Liabilities		 102 121 156 138 197 267 247 196 207 195 202
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,443 1,544 1,887 1,995 2,263 2,540 2,803 3,040 3,541 3,794 4,026
Total Preferred & Common Equity		 1,443 1,544 1,887 1,995 2,263 2,540 2,803 3,039 3,541 3,795 4,028
Preferred Stock		 - - - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Common Equity		 1,443 1,544 1,887 1,995 2,263 2,540 2,803 3,039 3,541 3,795 4,028
Common Stock		 681 698 718 739 761 776 797 818 840 866 893
Retained Earnings		 1,667 1,835 2,058 2,342 2,615 2,842 3,127 3,532 3,934 4,230 4,500
Treasury Stock		 -757 -787 -800 -957 -986 -1,064 -1,050 -1,184 -1,187 -1,170 -1,423
Accumulated Other Comprehensive Income / (Loss)		 -146 -202 -90 -129 -127 -14 -70 -126 -46 -131 58
Noncontrolling Interest		 - - - - 0.00 0.10 0.00 0.30 -0.20 -0.60 -1.30

Quarterly Balance Sheets for IDEX

This table presents IDEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 5,670 5,865 5,889 5,903 6,968 6,745 6,795 6,876 6,970 6,919 6,930
Total Current Assets		 1,518 1,446 1,555 1,630 1,678 1,593 1,627 1,617 1,655 1,717 1,773
Cash & Equivalents		 563 534 616 701 633 621 594 568 594 586 621
Accounts Receivable		 431 428 438 426 475 466 483 476 500 553 548
Inventories, net		 447 421 426 428 488 430 466 488 495 501 520
Other Current Assets		 78 63 74 75 81 76 84 84 66 77 84
Plant, Property, & Equipment, net		 422 430 428 419 469 460 460 465 469 462 464
Total Noncurrent Assets		 3,730 3,989 3,907 3,855 4,821 4,692 4,709 4,795 4,846 4,740 4,693
Goodwill		 2,677 2,838 2,803 2,787 3,316 3,252 3,287 3,369 3,409 3,390 3,383
Intangible Assets		 920 1,012 969 931 1,349 1,285 1,268 1,269 1,282 1,200 1,165
Other Noncurrent Operating Assets		 133 139 135 137 156 156 154 157 156 149 146
Total Liabilities & Shareholders' Equity		 5,670 5,865 5,889 5,903 6,968 6,745 6,795 6,876 6,970 6,919 6,930
Total Liabilities		 2,282 2,324 2,271 2,250 3,149 2,951 2,889 2,866 2,960 2,870 2,923
Total Current Liabilities		 488 500 461 477 565 630 584 530 564 506 582
Short-Term Debt		 0.70 0.60 0.70 0.60 0.60 101 101 0.80 0.70 0.50 0.40
Accounts Payable		 176 180 186 172 210 198 208 204 208 225 234
Accrued Expenses		 262 272 274 252 301 279 275 271 302 281 294
Dividends Payable		 49 49 0.00 52 52 53 0.00 54 53 0.10 54
Total Noncurrent Liabilities		 1,795 1,824 1,811 1,773 2,585 2,322 2,306 2,336 2,396 2,364 2,342
Long-Term Debt		 1,321 1,325 1,323 1,297 2,075 1,860 1,839 1,847 1,902 1,872 1,859
Noncurrent Deferred & Payable Income Tax Liabilities		 279 292 286 281 301 267 273 283 288 300 298
Other Noncurrent Operating Liabilities		 195 207 202 194 208 195 193 206 206 193 186
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 3,387 3,541 3,618 3,653 3,818 3,794 3,906 4,010 4,010 4,048 4,007
Total Preferred & Common Equity		 3,387 3,541 3,619 3,654 3,819 3,795 3,907 4,012 4,011 4,050 4,008
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 3,387 3,541 3,619 3,654 3,819 3,795 3,907 4,012 4,011 4,050 4,008
Common Stock		 837 840 852 857 861 866 879 885 889 869 876
Retained Earnings		 3,874 3,934 4,056 4,093 4,159 4,230 4,326 4,350 4,425 4,620 4,655
Treasury Stock		 -1,178 -1,187 -1,179 -1,179 -1,177 -1,170 -1,221 -1,271 -1,348 -1,454 -1,525
Accumulated Other Comprehensive Income / (Loss)		 -146 -46 -110 -116 -25 -131 -77 48 45 14 1.60
Noncontrolling Interest		 0.10 -0.20 -0.30 -0.40 -0.60 -0.60 -0.70 -1.20 -1.30 -1.40 -1.40

Annual Metrics And Ratios for IDEX

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.92% 4.57% 8.25% 8.58% 0.44% -5.73% 17.57% 15.09% 2.89% -0.16% 5.77%
EBITDA Growth		 0.15% -2.22% 16.60% 11.31% 0.54% -8.42% 20.57% 25.70% 5.97% -10.86% 5.13%
EBIT Growth		 -0.08% -4.57% 20.77% 14.58% 0.72% -10.76% 20.52% 27.27% 2.77% -15.79% 1.93%
NOPAT Growth		 -1.64% 5.91% 14.26% 20.89% 4.66% -9.52% 18.01% 19.17% -2.46% -6.85% -0.21%
Net Income Growth		 1.22% -4.14% 24.40% 21.74% 3.64% -11.21% 18.93% 30.58% 1.52% -15.28% -4.38%
EPS Growth		 4.93% -2.49% 23.51% 21.33% 5.10% -11.15% 19.03% 31.12% 1.82% -15.41% -3.46%
Operating Cash Flow Growth		 -2.08% 10.99% 8.21% 10.77% 10.17% 7.80% -0.70% -1.40% 28.58% -6.78% 1.84%
Free Cash Flow Firm Growth		 -52.21% -126.71% 762.62% 35.86% -17.60% -4.02% -126.12% -301.05% 188.87% -185.45% 247.71%
Invested Capital Growth		 6.63% 18.54% 2.09% 0.50% 4.49% 3.11% 22.43% 29.70% 6.24% 18.37% 2.58%
Revenue Q/Q Growth		 -1.18% 1.47% 2.49% 1.15% -0.32% 0.37% 3.75% 3.11% -0.66% 2.32% 1.06%
EBITDA Q/Q Growth		 0.88% -2.33% 8.90% 0.49% -0.83% 1.61% 4.15% 1.98% -1.80% 3.27% 2.13%
EBIT Q/Q Growth		 0.70% -3.31% 11.06% 0.93% -1.16% 1.50% 3.70% 1.65% -2.85% 2.41% 2.35%
NOPAT Q/Q Growth		 -0.79% 5.92% 3.38% 2.51% 0.05% 0.39% 3.63% 2.33% -2.49% 1.99% 1.08%
Net Income Q/Q Growth		 2.22% -3.70% 12.10% 1.08% -0.31% 1.14% 4.08% 1.96% -3.52% 3.04% 1.07%
EPS Q/Q Growth		 2.55% -3.55% 12.08% 1.15% 0.00% 0.82% 4.26% 2.12% -3.33% 2.63% 1.58%
Operating Cash Flow Q/Q Growth		 -0.78% 4.45% 4.99% 3.77% -0.45% 1.82% 0.30% 0.76% 4.93% -4.08% 5.73%
Free Cash Flow Firm Q/Q Growth		 -21.82% 65.94% -17.81% 9.96% -6.42% -2.89% -20.23% -196.86% 227.73% 54.53% -14.86%
Invested Capital Q/Q Growth		 -0.90% -3.79% -0.50% -1.64% -0.62% -0.15% 0.90% 22.79% 4.45% -2.39% -0.96%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.75% 44.05% 44.89% 45.01% 45.10% 43.69% 44.29% 44.84% 44.20% 44.21% 44.51%
EBITDA Margin		 25.42% 23.77% 25.61% 26.25% 26.28% 25.53% 26.18% 28.59% 29.45% 26.29% 26.13%
Operating Margin		 20.73% 20.57% 21.57% 22.91% 23.21% 22.14% 23.04% 23.61% 22.37% 20.72% 20.23%
EBIT Margin		 21.48% 19.60% 21.87% 23.07% 23.14% 21.90% 22.45% 24.83% 24.80% 20.92% 20.16%
Profit (Net Income) Margin		 14.00% 12.83% 14.74% 16.53% 17.06% 16.07% 16.25% 18.44% 18.19% 15.44% 13.96%
Tax Burden Percent		 72.08% 73.57% 74.08% 77.62% 79.85% 80.33% 77.49% 78.29% 78.34% 78.93% 76.27%
Interest Burden Percent		 90.41% 88.99% 91.03% 92.30% 92.33% 91.30% 93.40% 94.85% 93.63% 93.49% 90.76%
Effective Tax Rate		 27.92% 26.43% 25.92% 22.38% 20.15% 19.67% 22.51% 21.71% 21.66% 21.07% 23.73%
Return on Invested Capital (ROIC)		 15.72% 14.77% 15.39% 18.37% 18.76% 16.35% 17.09% 16.11% 13.49% 11.17% 10.15%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.52% 7.52% 11.12% 11.65% 7.79% -9.59% -3.38% 15.90% 15.76% 8.49% 6.37%
Return on Net Nonoperating Assets (RNNOA)		 3.58% 3.39% 4.27% 2.79% 1.23% -0.62% -0.27% 3.97% 4.61% 2.58% 2.19%
Return on Equity (ROE)		 19.31% 18.15% 19.66% 21.16% 19.99% 15.73% 16.82% 20.08% 18.10% 13.76% 12.34%
Cash Return on Invested Capital (CROIC)		 9.31% -2.20% 13.33% 17.88% 14.37% 13.29% -3.07% -9.75% 7.44% -5.65% 7.60%
Operating Return on Assets (OROA)		 15.20% 13.90% 15.26% 16.67% 15.84% 12.52% 13.31% 15.15% 14.27% 10.84% 10.20%
Return on Assets (ROA)		 9.91% 9.10% 10.29% 11.95% 11.68% 9.18% 9.63% 11.25% 10.47% 8.00% 7.06%
Return on Common Equity (ROCE)		 19.31% 18.15% 19.66% 21.16% 19.99% 15.73% 16.82% 20.08% 18.10% 13.76% 12.34%
Return on Equity Simple (ROE_SIMPLE)		 19.59% 17.56% 17.88% 20.58% 18.80% 14.87% 16.03% 19.30% 16.82% 13.30% 0.00%
Net Operating Profit after Tax (NOPAT)		 302 320 365 442 462 418 494 588 574 535 533
NOPAT Margin		 14.94% 15.13% 15.98% 17.79% 18.53% 17.79% 17.85% 18.49% 17.53% 16.35% 15.43%
Net Nonoperating Expense Percent (NNEP)		 4.21% 7.24% 4.27% 6.72% 10.97% 25.94% 20.47% 0.21% -2.26% 2.68% 3.79%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 13.05% 11.79% 9.29% 9.12%
Cost of Revenue to Revenue		 55.25% 55.95% 55.11% 54.99% 54.90% 56.31% 55.71% 55.16% 55.81% 55.79% 55.49%
SG&A Expenses to Revenue		 23.47% 23.30% 22.95% 21.61% 21.05% 21.05% 20.91% 20.51% 21.49% 23.21% 23.68%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 24.02% 23.48% 23.32% 22.10% 21.89% 21.55% 21.25% 21.23% 21.82% 23.49% 24.28%
Earnings before Interest and Taxes (EBIT)		 434 414 500 573 577 515 621 790 812 684 697
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 514 502 586 652 656 600 724 910 964 859 904
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.64 4.05 4.93 4.54 5.47 5.69 6.20 5.51 4.56 4.16 3.29
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 129.71 63.08 456.23 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.60 2.96 4.07 3.64 4.96 6.14 6.29 5.26 4.94 4.83 3.84
Price to Earnings (P/E)		 18.57 23.07 27.60 22.05 29.10 38.24 38.68 28.54 27.11 31.28 27.46
Dividend Yield		 1.81% 1.63% 1.19% 1.41% 1.19% 1.05% 0.93% 1.05% 1.18% 1.30% 1.59%
Earnings Yield		 5.38% 4.33% 3.62% 4.54% 3.44% 2.62% 2.59% 3.50% 3.69% 3.20% 3.64%
Enterprise Value to Invested Capital (EV/IC)		 2.91 2.99 4.08 3.91 5.00 5.57 5.57 4.31 3.87 3.30 2.73
Enterprise Value to Revenue (EV/Rev)		 2.85 3.33 4.28 3.80 5.05 6.15 6.41 5.59 5.18 5.24 4.20
Enterprise Value to EBITDA (EV/EBITDA)		 11.22 14.00 16.72 14.47 19.22 24.09 24.48 19.55 17.58 19.94 16.06
Enterprise Value to EBIT (EV/EBIT)		 13.28 16.98 19.58 16.46 21.83 28.08 28.54 22.52 20.87 25.06 20.82
Enterprise Value to NOPAT (EV/NOPAT)		 19.09 21.99 26.80 21.36 27.25 34.58 35.89 30.24 29.54 32.06 27.20
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.00 17.59 22.63 19.68 23.85 25.41 31.34 31.91 23.65 25.65 21.33
Enterprise Value to Free Cash Flow (EV/FCFF)		 32.25 0.00 30.95 21.95 35.57 42.55 0.00 0.00 53.56 0.00 36.33
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.58 0.66 0.46 0.43 0.38 0.41 0.42 0.48 0.37 0.52 0.45
Long-Term Debt to Equity		 0.58 0.66 0.46 0.43 0.38 0.41 0.42 0.48 0.37 0.49 0.45
Financial Leverage		 0.31 0.45 0.38 0.24 0.16 0.07 0.08 0.25 0.29 0.30 0.34
Leverage Ratio		 1.95 2.00 1.91 1.77 1.71 1.71 1.75 1.79 1.73 1.72 1.75
Compound Leverage Factor		 1.76 1.78 1.74 1.63 1.58 1.56 1.63 1.69 1.62 1.61 1.59
Debt to Total Capital		 36.78% 39.65% 31.28% 29.85% 27.29% 29.14% 29.81% 32.58% 27.24% 34.07% 31.14%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.02% 0.01% 0.00% 0.00% 0.00% 0.01% 1.75% 0.01%
Long-Term Debt to Total Capital		 36.78% 39.65% 31.28% 29.83% 27.27% 29.13% 29.81% 32.58% 27.23% 32.32% 31.13%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% -0.01% -0.02%
Common Equity to Total Capital		 63.22% 60.35% 68.72% 70.15% 72.71% 70.86% 70.19% 67.42% 72.77% 65.95% 68.88%
Debt to EBITDA		 1.63 2.02 1.47 1.30 1.30 1.74 1.64 1.61 1.38 2.28 2.02
Net Debt to EBITDA		 1.00 1.55 0.82 0.59 0.33 0.03 0.46 1.14 0.82 1.56 1.37
Long-Term Debt to EBITDA		 1.63 2.02 1.47 1.30 1.30 1.74 1.64 1.61 1.37 2.16 2.01
Debt to NOPAT		 2.78 3.17 2.35 1.92 1.84 2.50 2.41 2.50 2.31 3.67 3.41
Net Debt to NOPAT		 1.69 2.43 1.32 0.87 0.47 0.04 0.68 1.77 1.38 2.51 2.33
Long-Term Debt to NOPAT		 2.78 3.17 2.35 1.92 1.84 2.50 2.41 2.50 2.31 3.48 3.41
Altman Z-Score		 4.61 4.44 5.92 6.13 7.19 6.79 7.09 6.20 6.32 5.08 4.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% -0.01% -0.02%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.79 2.66 2.78 3.00 3.52 4.15 3.50 2.57 2.89 2.53 2.86
Quick Ratio		 1.90 1.65 1.86 2.14 2.60 3.31 2.52 1.61 1.92 1.73 1.91
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 179 -48 316 430 354 340 -89 -356 316 -270 399
Operating Cash Flow to CapEx		 823.10% 1,045.75% 986.71% 860.18% 1,037.52% 1,103.29% 777.58% 819.71% 797.22% 1,026.27% 1,069.81%
Free Cash Flow to Firm to Interest Expense		 4.29 -1.05 7.05 9.74 7.99 7.59 -2.17 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 8.65 8.77 9.64 10.86 11.92 12.71 13.79 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 7.60 7.93 8.66 9.60 10.77 11.56 12.01 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.71 0.71 0.70 0.72 0.68 0.57 0.59 0.61 0.58 0.52 0.51
Accounts Receivable Turnover		 7.83 7.93 8.07 8.19 8.17 7.95 8.51 7.96 7.52 7.32 7.00
Inventory Turnover		 4.68 4.81 4.92 5.06 4.78 4.54 4.67 4.17 4.10 4.29 4.22
Fixed Asset Turnover		 8.78 8.65 9.04 9.21 8.88 8.13 8.84 8.97 8.06 7.34 7.45
Accounts Payable Turnover		 8.71 9.17 9.14 9.41 9.73 9.12 9.31 9.05 9.40 9.66 9.08
Days Sales Outstanding (DSO)		 46.61 46.02 45.24 44.56 44.65 45.89 42.87 45.84 48.53 49.90 52.13
Days Inventory Outstanding (DIO)		 77.94 75.94 74.21 72.12 76.41 80.40 78.23 87.49 89.07 85.12 86.47
Days Payable Outstanding (DPO)		 41.91 39.80 39.96 38.79 37.53 40.03 39.19 40.32 38.82 37.78 40.19
Cash Conversion Cycle (CCC)		 82.63 82.16 79.49 77.89 83.54 86.26 81.91 93.01 98.79 97.23 98.41
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,982 2,350 2,399 2,410 2,519 2,597 3,179 4,124 4,381 5,186 5,320
Invested Capital Turnover		 1.05 0.98 0.96 1.03 1.01 0.92 0.96 0.87 0.77 0.68 0.66
Increase / (Decrease) in Invested Capital		 123 368 49 12 108 78 582 944 257 805 134
Enterprise Value (EV)		 5,765 7,033 9,793 9,434 12,598 14,464 17,717 17,789 16,949 17,137 14,510
Market Capitalization		 5,253 6,255 9,310 9,052 12,381 14,445 17,382 16,750 16,158 15,798 13,270
Book Value per Share		 $18.86 $20.25 $24.69 $26.00 $29.76 $33.55 $36.87 $40.30 $46.83 $50.11 $53.81
Tangible Book Value per Share		 ($3.15) ($6.88) ($3.04) ($1.13) $1.26 $3.02 $0.50 ($7.25) ($4.08) ($9.80) ($8.48)
Total Capital		 2,283 2,558 2,745 2,843 3,112 3,585 3,993 4,508 4,867 5,754 5,847
Total Debt		 840 1,014 859 849 849 1,045 1,190 1,469 1,326 1,960 1,821
Total Long-Term Debt		 840 1,014 859 848 849 1,044 1,190 1,469 1,325 1,860 1,820
Net Debt		 512 778 483 382 217 19 335 1,039 791 1,339 1,241
Capital Expenditures (CapEx)		 44 38 44 56 51 52 73 68 90 65 64
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 225 278 267 262 271 232 343 426 412 443 489
Debt-free Net Working Capital (DFNWC)		 553 514 643 728 904 1,258 1,198 856 947 1,064 1,069
Net Working Capital (NWC)		 553 514 643 728 904 1,258 1,198 856 946 963 1,068
Net Nonoperating Expense (NNE)		 19 49 28 31 37 40 44 1.57 -22 30 51
Net Nonoperating Obligations (NNO)		 539 806 512 416 255 57 376 1,084 840 1,392 1,294
Total Depreciation and Amortization (D&A)		 80 88 86 79 78 85 103 120 152 176 207
Debt-free, Cash-free Net Working Capital to Revenue		 11.14% 13.14% 11.68% 10.55% 10.88% 9.88% 12.39% 13.37% 12.59% 13.55% 14.13%
Debt-free Net Working Capital to Revenue		 27.37% 24.30% 28.11% 29.33% 36.24% 53.51% 43.33% 26.89% 28.91% 32.54% 30.90%
Net Working Capital to Revenue		 27.37% 24.30% 28.11% 29.31% 36.22% 53.50% 43.33% 26.89% 28.90% 29.46% 30.88%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.65 $3.57 $4.41 $5.36 $5.62 $4.98 $5.91 $7.74 $7.87 $6.66 $6.41
Adjusted Weighted Average Basic Shares Outstanding		 77.13M 75.80M 76.23M 76.41M 75.59M 75.74M 76M 75.70M 75.60M 75.70M 75.30M
Adjusted Diluted Earnings per Share		 $3.62 $3.53 $4.36 $5.29 $5.56 $4.94 $5.88 $7.71 $7.85 $6.64 $6.41
Adjusted Weighted Average Diluted Shares Outstanding		 77.97M 76.76M 77.33M 77.56M 76.45M 76.40M 76.40M 76M 75.90M 75.90M 75.30M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 75.93M 76.25M 76.54M 75.79M 76.21M 75.89M 76.12M 75.52M 75.64M 75.78M 74.35M
Normalized Net Operating Profit after Tax (NOPAT)		 310 323 372 451 479 428 501 606 582 542 549
Normalized NOPAT Margin		 15.34% 15.26% 16.25% 18.16% 19.20% 18.19% 18.11% 19.05% 17.79% 16.58% 15.88%
Pre Tax Income Margin		 19.42% 17.44% 19.90% 21.30% 21.36% 20.00% 20.97% 23.55% 23.22% 19.56% 18.30%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 10.42 9.08 11.14 12.98 13.03 11.50 15.14 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 7.25 7.01 8.14 10.01 10.44 9.34 12.04 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 9.37 8.24 10.17 11.72 11.88 10.35 13.37 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 6.20 6.17 7.16 8.75 9.29 8.19 10.27 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 34.01% 37.86% 32.96% 31.05% 34.59% 40.18% 35.86% 30.24% 32.02% 40.69% 44.06%
Augmented Payout Ratio		 108.55% 58.99% 41.58% 73.41% 47.45% 69.38% 35.86% 55.48% 36.08% 40.69% 95.42%

Quarterly Metrics And Ratios for IDEX

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 74,347,824.00 74,015,052.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 74,347,824.00 74,015,052.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 1.61 1.94
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -2.69% -5.31% -4.61% 0.61% 9.38% 1.72% 7.21% 10.09% 4.20% 8.92% 6.38%
EBITDA Growth		 -8.46% -10.73% -0.83% -33.57% 14.21% -6.94% 3.96% 14.62% 8.60% 19.00% 7.65%
EBIT Growth		 -13.55% -15.03% -2.35% -40.22% 10.61% -14.22% -0.96% 13.54% 9.53% 23.04% 8.46%
NOPAT Growth		 -10.90% -15.36% -7.28% -9.77% 8.64% -14.03% 0.72% 7.56% 4.29% 21.00% 6.24%
Net Income Growth		 -16.69% -13.23% 1.95% -43.11% 13.76% -21.35% -7.15% 7.40% 4.14% 25.68% 9.38%
EPS Growth		 -15.79% -13.04% 2.20% -42.91% 11.81% -21.25% -6.45% 8.28% 6.21% 27.78% 10.92%
Operating Cash Flow Growth		 20.14% 5.88% -5.38% -9.40% -14.13% -32.50% 21.03% -0.88% 21.38% -1.89% 23.69%
Free Cash Flow Firm Growth		 83.43% 98.60% 125.44% -42.80% -402.34% -8,466.17% -588.45% 108.14% 100.96% 105.95% 122.27%
Invested Capital Growth		 6.24% 3.25% -0.91% 26.67% 18.37% 21.41% 24.18% 1.10% 2.58% 1.58% -0.85%
Revenue Q/Q Growth		 -0.57% 1.47% 0.84% -1.12% 8.11% -5.63% 6.28% 1.54% 2.32% -1.36% 3.80%
EBITDA Q/Q Growth		 -39.04% 6.95% 11.14% -8.31% 4.79% -12.85% 24.15% 1.10% -0.71% -4.51% 12.31%
EBIT Q/Q Growth		 -44.90% 7.97% 14.28% -12.07% 1.94% -16.26% 31.93% 0.81% -1.66% -5.93% 16.30%
NOPAT Q/Q Growth		 -13.53% 2.08% 13.75% -10.13% 4.11% -19.21% 33.25% -4.02% 0.94% -6.27% 16.99%
Net Income Q/Q Growth		 -48.18% 12.00% 16.41% -15.79% 3.62% -22.56% 37.42% -2.59% 0.47% -6.55% 19.60%
EPS Q/Q Growth		 -47.64% 11.11% 16.25% -15.59% 2.55% -21.74% 38.10% -2.30% 0.59% -5.85% 19.88%
Operating Cash Flow Q/Q Growth		 -11.30% -22.09% -14.69% 53.67% -15.93% -38.76% 52.98% 25.85% 2.95% -50.50% 92.86%
Free Cash Flow Firm Q/Q Growth		 80.74% 92.85% 2,022.04% -639.56% 32.26% -21.93% -9.60% 108.99% -91.98% 652.75% 309.84%
Invested Capital Q/Q Growth		 4.45% -1.27% -0.52% 23.48% -2.39% 1.26% 1.75% 0.53% -0.96% 0.27% -0.68%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 42.69% 44.65% 45.44% 44.34% 42.54% 45.30% 45.32% 44.45% 43.05% 44.89% 46.36%
EBITDA Margin		 24.26% 25.57% 28.18% 26.13% 25.33% 23.39% 27.33% 27.21% 26.40% 25.56% 27.66%
Operating Margin		 20.34% 20.14% 22.63% 21.05% 19.16% 17.44% 21.71% 21.14% 20.42% 19.44% 21.71%
EBIT Margin		 19.24% 20.47% 23.20% 20.63% 19.46% 17.27% 21.44% 21.28% 20.45% 19.51% 21.86%
Profit (Net Income) Margin		 13.73% 15.15% 17.49% 14.90% 14.28% 11.72% 15.15% 14.53% 14.27% 13.52% 15.58%
Tax Burden Percent		 77.25% 78.51% 78.79% 77.01% 81.48% 76.63% 77.16% 74.90% 76.51% 76.37% 77.06%
Interest Burden Percent		 92.36% 94.26% 95.68% 93.75% 90.05% 88.55% 91.59% 91.18% 91.19% 90.75% 92.50%
Effective Tax Rate		 22.75% 21.49% 21.21% 22.99% 18.52% 23.37% 22.84% 25.10% 23.49% 23.63% 22.94%
Return on Invested Capital (ROIC)		 12.10% 11.99% 13.16% 10.89% 10.67% 9.16% 11.60% 10.14% 10.28% 9.90% 11.27%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.47% 11.36% 12.84% 9.98% 9.64% 7.85% 10.20% 9.34% 9.38% 9.01% 10.46%
Return on Net Nonoperating Assets (RNNOA)		 3.06% 2.77% 3.17% 3.19% 2.93% 2.14% 2.64% 3.41% 3.22% 2.98% 3.43%
Return on Equity (ROE)		 15.16% 14.76% 16.33% 14.08% 13.60% 11.30% 14.24% 13.55% 13.50% 12.88% 14.70%
Cash Return on Invested Capital (CROIC)		 7.44% 9.74% 13.38% -12.51% -5.65% -8.54% -10.84% 8.78% 7.60% 8.94% 11.48%
Operating Return on Assets (OROA)		 11.07% 11.45% 12.74% 10.43% 10.09% 8.94% 11.21% 10.45% 10.34% 10.04% 11.35%
Return on Assets (ROA)		 7.90% 8.47% 9.60% 7.53% 7.40% 6.06% 7.92% 7.14% 7.22% 6.96% 8.09%
Return on Common Equity (ROCE)		 15.16% 14.76% 16.33% 14.08% 13.60% 11.30% 14.25% 13.55% 13.51% 12.88% 14.70%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 15.95% 15.87% 12.82% 0.00% 12.25% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 124 127 144 129 135 109 145 139 140 132 154
NOPAT Margin		 15.72% 15.81% 17.83% 16.21% 15.61% 13.36% 16.75% 15.84% 15.62% 14.85% 16.73%
Net Nonoperating Expense Percent (NNEP)		 1.63% 0.63% 0.32% 0.91% 1.03% 1.31% 1.40% 0.80% 0.91% 0.89% 0.81%
Return On Investment Capital (ROIC_SIMPLE)		 2.55% - - - 2.34% 1.86% 2.47% 2.35% 2.40% 2.22% 2.63%
Cost of Revenue to Revenue		 57.31% 55.35% 54.56% 55.66% 57.46% 54.70% 54.68% 55.55% 56.95% 55.11% 53.64%
SG&A Expenses to Revenue		 22.01% 24.37% 22.65% 22.91% 22.93% 25.72% 23.53% 23.30% 22.37% 24.61% 24.34%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 22.35% 24.51% 22.81% 23.29% 23.39% 27.86% 23.61% 23.31% 22.63% 25.45% 24.65%
Earnings before Interest and Taxes (EBIT)		 152 164 187 165 168 141 186 187 184 173 201
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 191 205 228 209 219 191 237 239 237 227 255
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.56 5.07 4.15 4.24 4.16 3.51 3.29 3.04 3.29 3.48 4.18
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 4.94 5.68 4.76 5.07 4.83 4.18 3.95 3.57 3.84 3.99 4.67
Price to Earnings (P/E)		 27.11 31.74 26.15 33.00 31.28 28.63 28.15 25.52 27.46 27.76 32.23
Dividend Yield		 1.18% 1.06% 1.62% 1.24% 1.30% 1.53% 1.59% 1.73% 1.59% 1.50% 1.26%
Earnings Yield		 3.69% 3.15% 3.82% 3.03% 3.20% 3.49% 3.55% 3.92% 3.64% 3.60% 3.10%
Enterprise Value to Invested Capital (EV/IC)		 3.87 4.40 3.67 3.32 3.30 2.87 2.71 2.51 2.73 2.88 3.39
Enterprise Value to Revenue (EV/Rev)		 5.18 5.90 4.95 5.52 5.24 4.59 4.34 3.95 4.20 4.36 5.01
Enterprise Value to EBITDA (EV/EBITDA)		 17.58 20.27 16.82 21.18 19.94 17.82 16.96 15.27 16.06 16.36 18.77
Enterprise Value to EBIT (EV/EBIT)		 20.87 24.32 20.26 26.40 25.06 22.80 22.00 19.84 20.82 21.08 24.13
Enterprise Value to NOPAT (EV/NOPAT)		 29.54 34.58 29.26 33.63 32.06 29.13 27.98 25.60 27.20 27.64 31.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 23.65 26.25 21.98 25.31 25.65 24.40 22.46 20.99 21.33 22.67 25.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 53.56 45.93 27.27 0.00 0.00 0.00 0.00 28.80 36.33 32.49 29.44
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.37 0.37 0.36 0.54 0.52 0.50 0.46 0.47 0.45 0.46 0.46
Long-Term Debt to Equity		 0.37 0.37 0.36 0.54 0.49 0.47 0.46 0.47 0.45 0.46 0.46
Financial Leverage		 0.29 0.24 0.25 0.32 0.30 0.27 0.26 0.36 0.34 0.33 0.33
Leverage Ratio		 1.73 1.69 1.68 1.75 1.72 1.69 1.67 1.78 1.75 1.72 1.72
Compound Leverage Factor		 1.60 1.59 1.60 1.64 1.55 1.49 1.53 1.62 1.59 1.56 1.59
Debt to Total Capital		 27.24% 26.78% 26.21% 35.22% 34.07% 33.18% 31.54% 32.17% 31.14% 31.62% 31.69%
Short-Term Debt to Total Capital		 0.01% 0.01% 0.01% 0.01% 1.75% 1.72% 0.01% 0.01% 0.01% 0.01% 0.01%
Long-Term Debt to Total Capital		 27.23% 26.77% 26.20% 35.21% 32.32% 31.46% 31.53% 32.16% 31.13% 31.61% 31.69%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -0.01% -0.01% -0.01% -0.01% -0.01% -0.02% -0.02% -0.02% -0.02% -0.02%
Common Equity to Total Capital		 72.77% 73.22% 73.79% 64.79% 65.95% 66.83% 68.48% 67.85% 68.88% 68.40% 68.33%
Debt to EBITDA		 1.38 1.41 1.38 2.49 2.28 2.30 2.16 2.15 2.02 1.99 1.94
Net Debt to EBITDA		 0.82 0.75 0.64 1.73 1.56 1.59 1.50 1.48 1.37 1.37 1.29
Long-Term Debt to EBITDA		 1.37 1.41 1.38 2.49 2.16 2.18 2.16 2.15 2.01 1.99 1.94
Debt to NOPAT		 2.31 2.40 2.41 3.96 3.67 3.75 3.57 3.61 3.41 3.37 3.29
Net Debt to NOPAT		 1.38 1.28 1.11 2.75 2.51 2.60 2.47 2.48 2.33 2.31 2.19
Long-Term Debt to NOPAT		 2.31 2.40 2.41 3.96 3.48 3.56 3.57 3.60 3.41 3.37 3.29
Altman Z-Score		 5.95 6.67 5.90 4.65 4.83 4.47 4.42 4.13 4.43 4.68 5.20
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% -0.01% -0.01% -0.01% -0.02% -0.02% -0.02% -0.03% -0.03%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.89 3.37 3.41 2.97 2.53 2.79 3.05 2.93 2.86 3.39 3.05
Quick Ratio		 1.92 2.29 2.36 1.96 1.73 1.84 1.97 1.94 1.91 2.25 2.01
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -133 -9.54 183 -989 -670 -817 -896 81 6.46 49 199
Operating Cash Flow to CapEx		 930.56% 783.00% 840.25% 1,498.54% 1,113.55% 739.16% 1,092.57% 1,375.00% 1,063.45% 585.88% 869.57%
Free Cash Flow to Firm to Interest Expense		 0.00 -1.01 22.64 -96.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 16.66 16.49 19.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 14.53 14.53 18.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.58 0.56 0.55 0.51 0.52 0.52 0.52 0.49 0.51 0.51 0.52
Accounts Receivable Turnover		 7.52 7.30 7.24 7.05 7.32 7.13 7.41 7.02 7.00 6.82 7.00
Inventory Turnover		 4.10 3.91 3.91 3.81 4.29 4.09 4.06 3.87 4.22 4.06 3.93
Fixed Asset Turnover		 8.06 7.83 7.59 7.18 7.34 7.39 7.56 7.30 7.45 7.66 7.72
Accounts Payable Turnover		 9.40 9.00 9.83 9.21 9.66 9.27 9.87 9.09 9.08 9.06 9.06
Days Sales Outstanding (DSO)		 48.53 49.99 50.42 51.74 49.90 51.18 49.29 52.02 52.13 53.54 52.12
Days Inventory Outstanding (DIO)		 89.07 93.27 93.37 95.85 85.12 89.19 89.91 94.32 86.47 89.97 92.79
Days Payable Outstanding (DPO)		 38.82 40.58 37.14 39.65 37.78 39.39 36.98 40.15 40.19 40.28 40.31
Cash Conversion Cycle (CCC)		 98.79 102.68 106.66 107.94 97.23 100.97 102.22 106.20 98.41 103.23 104.60
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,381 4,326 4,303 5,313 5,186 5,252 5,344 5,372 5,320 5,335 5,298
Invested Capital Turnover		 0.77 0.76 0.74 0.67 0.68 0.69 0.69 0.64 0.66 0.67 0.67
Increase / (Decrease) in Invested Capital		 257 136 -39 1,119 805 926 1,041 59 134 83 -45
Enterprise Value (EV)		 16,949 19,042 15,775 17,627 17,137 15,060 14,491 13,508 14,510 15,377 17,979
Market Capitalization		 16,158 18,335 15,178 16,185 15,798 13,715 13,213 12,201 13,270 14,093 16,743
Book Value per Share		 $46.83 $47.80 $48.27 $50.45 $50.11 $51.55 $53.10 $53.28 $53.81 $54.47 $54.15
Tangible Book Value per Share		 ($4.08) ($2.03) ($0.85) ($11.18) ($9.80) ($8.56) ($8.29) ($9.02) ($8.48) ($7.27) ($7.28)
Total Capital		 4,867 4,942 4,951 5,894 5,754 5,846 5,858 5,912 5,847 5,921 5,866
Total Debt		 1,326 1,324 1,298 2,076 1,960 1,940 1,848 1,902 1,821 1,872 1,859
Total Long-Term Debt		 1,325 1,323 1,297 2,075 1,860 1,839 1,847 1,902 1,820 1,872 1,859
Net Debt		 791 707 597 1,443 1,339 1,346 1,280 1,309 1,241 1,286 1,238
Capital Expenditures (CapEx)		 22 20 16 14 16 14 15 15 20 18 23
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 412 478 452 481 443 550 519 498 489 625 571
Debt-free Net Working Capital (DFNWC)		 947 1,095 1,153 1,114 1,064 1,144 1,088 1,092 1,069 1,211 1,192
Net Working Capital (NWC)		 946 1,094 1,152 1,113 963 1,043 1,087 1,091 1,068 1,211 1,192
Net Nonoperating Expense (NNE)		 16 5.26 2.76 10 11 13 14 11 12 12 11
Net Nonoperating Obligations (NNO)		 840 707 650 1,495 1,392 1,346 1,333 1,362 1,294 1,286 1,292
Total Depreciation and Amortization (D&A)		 40 41 40 44 51 50 51 52 54 54 53
Debt-free, Cash-free Net Working Capital to Revenue		 12.59% 14.81% 14.17% 15.04% 13.55% 16.75% 15.54% 14.55% 14.13% 17.70% 15.92%
Debt-free Net Working Capital to Revenue		 28.91% 33.90% 36.13% 34.86% 32.54% 34.84% 32.55% 31.91% 30.90% 34.31% 33.25%
Net Working Capital to Revenue		 28.90% 33.88% 36.12% 34.84% 29.46% 31.78% 32.53% 31.89% 30.88% 34.30% 33.24%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.43 $1.60 $1.86 $1.57 $1.63 $1.26 $1.74 $1.70 $1.71 $1.61 $1.94
Adjusted Weighted Average Basic Shares Outstanding		 75.60M 75.70M 75.70M 75.70M 75.70M 75.70M 75.50M 75.10M 75.30M 74.30M 74M
Adjusted Diluted Earnings per Share		 $1.44 $1.60 $1.86 $1.57 $1.61 $1.26 $1.74 $1.70 $1.71 $1.61 $1.93
Adjusted Weighted Average Diluted Shares Outstanding		 75.90M 75.90M 75.90M 75.90M 75.90M 75.80M 75.50M 75.20M 75.30M 74.40M 74.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 75.64M 75.70M 75.70M 75.72M 75.78M 75.54M 75.29M 74.85M 74.35M 74.02M 73.72M
Normalized Net Operating Profit after Tax (NOPAT)		 126 127 145 132 138 122 146 139 142 137 156
Normalized NOPAT Margin		 15.98% 15.92% 17.96% 16.50% 15.98% 15.01% 16.82% 15.85% 15.83% 15.48% 16.97%
Pre Tax Income Margin		 17.77% 19.30% 22.20% 19.34% 17.52% 15.29% 19.63% 19.40% 18.65% 17.70% 20.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 17.44 23.12 15.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 13.46 17.77 12.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 15.31 21.16 14.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 11.34 15.81 11.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 32.02% 33.56% 34.06% 41.13% 40.69% 43.70% 44.92% 44.34% 44.06% 42.01% 41.09%
Augmented Payout Ratio		 36.08% 33.56% 38.06% 45.84% 40.69% 54.15% 66.26% 81.00% 95.42% 96.08% 99.09%

Financials Breakdown Chart

Key Financial Trends

IDEX (NYSE:IEX) showed a solid start to 2026, with revenue growth, stable margins, and strong cash generation, but the balance sheet still reflects a large acquisition-driven goodwill and intangibles base.

For Q1 2026, revenue rose to $886.9 million from $814.3 million in Q1 2025, a gain of about 8.9%. Operating income improved to $172.4 million versus $142.0 million a year ago, and diluted EPS increased to $1.61 from $1.26. That points to better operating leverage even as the company continues to manage restructuring costs and a meaningful debt load.

  • Revenue is trending higher year over year. Q1 2026 revenue increased 8.9% from Q1 2025, showing healthy top-line momentum.
  • Operating profit improved meaningfully. Operating income rose to $172.4 million from $142.0 million, indicating better profitability on higher sales.
  • Margins held up well. Gross profit was $398.1 million, and operating income remained strong despite restructuring expenses.
  • Quarterly earnings improved. Net income attributable to common shareholders was $120.0 million, up from $95.5 million in Q1 2025.
  • Operating cash flow was strong. Q1 2026 operating cash flow came in at $103.7 million, supporting the business’s ability to fund dividends and buybacks.
  • The company continued returning capital to shareholders. IDEX paid $52.8 million in dividends and repurchased $76.3 million of stock in the quarter.
  • Shares outstanding were slightly lower than a year ago. Diluted weighted average shares fell to 74.4 million from 75.5 million in Q1 2025, helping EPS.
  • Cash on hand remains healthy. Cash and equivalents were $586.2 million at the end of Q1 2026.
  • Interest expense remains a drag. Interest and investment income was negative $16.0 million in Q1 2026, limiting pre-tax earnings growth.
  • Leverage is still significant. Long-term debt stood at $1.87 billion, and total liabilities were $2.87 billion versus equity of $4.05 billion.

Looking at the last several years, IDEX has generally shown steady revenue growth, resilient profitability, and dependable free-cash-flow generation. Quarterly revenue has moved from roughly $800 million in early 2024 to nearly $887 million in Q1 2026. Net income has also remained consistently above $100 million per quarter, which suggests a durable earnings base.

One area to watch is the balance sheet. Total assets were $6.92 billion in Q1 2026, but a large portion is tied up in goodwill ($3.39 billion) and intangible assets ($1.20 billion). That is typical for an acquisition-driven industrial company, but it means investors should keep an eye on acquisition integration and any future impairment risk.

From a cash-flow perspective, the company has been able to support both dividends and buybacks while still generating positive operating cash flow. That is a constructive sign for retail investors, especially since IDEX has not needed to rely heavily on dilutive equity issuance. The main caution is that financing activity has been used to manage debt maturities, so the company’s capital structure is still something to monitor.

Bottom line: IDEX appears to be in good operational shape, with improving sales and earnings plus reliable cash generation. The stock’s longer-term story still depends on maintaining margin discipline, continuing debt reduction, and making sure acquisitions add value rather than just increasing goodwill.

08/15/26 05:15 AM ETAI Generated. May Contain Errors.

IDEX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IDEX's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

IDEX's net income appears to be on an upward trend, with a most recent value of $482.50 million in 2025, rising from $282.81 million in 2015. The previous period was $504.60 million in 2024. See where experts think IDEX is headed by visiting IDEX's forecast page.

IDEX's total operating income in 2025 was $699.30 million, based on the following breakdown:
  • Total Gross Profit: $1.54 billion
  • Total Operating Expenses: $839.50 million

Over the last 10 years, IDEX's total revenue changed from $2.02 billion in 2015 to $3.46 billion in 2025, a change of 71.1%.

IDEX's total liabilities were at $2.90 billion at the end of 2025, a 1.7% decrease from 2024, and a 113.0% increase since 2015.

In the past 10 years, IDEX's cash and equivalents has ranged from $235.96 million in 2016 to $1.03 billion in 2020, and is currently $580 million as of their latest financial filing in 2025.

Over the last 10 years, IDEX's book value per share changed from 18.86 in 2015 to 53.81 in 2025, a change of 185.3%.


Related Companies

Financial statements for NYSE:IEX last updated on 7/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel